WalzmUehlestrasse 49
Frauenfeld 8500
Switzerland
https://corporate.docmorris.com/en
Settore/i:
Settore:
Impiegati a tempo pieno: 1.453
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Walter Oberhansli | Founder & Chairman | 432k | N/D | 1958 |
Mr. Walter Hess | CEO & Member of Executive Board | 1,37M | N/D | 1965 |
Mr. Marcel Ziwica | CFO & Member of Executive Board | N/D | N/D | 1975 |
Mr. David Maso | Head of Europe & Member of Executive Board | N/D | N/D | 1971 |
Mr. Madhu Nutakki | CTO & Member of Executive Board | N/D | N/D | 1971 |
Mr. Kaspar Niklaus | COO & Member of Executive Board | N/D | N/D | 1968 |
Dr. Daniel Grigat | Group Head of Investor Relations & Sustainability | N/D | N/D | N/D |
Torben Bonnke | Director of Communications | N/D | N/D | N/D |
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
L'ISS Governance QualityScore di DocMorris AG al 1 settembre 2024 è 6. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 4; diritti degli azionisti: 1; retribuzione: 8.